Silodosin (8mg), Solifenacin (5mg)
Maxvoid S Tablet is an effective combination medication engineered to manage benign prostatic hyperplasia (BPH) accompanied by overactive bladder symptoms. It helps relax urinary tract muscles and reduces involuntary bladder contractions to ease urination.
Relief of urinary symptoms caused by benign prostatic hyperplasia and management of urinary urgency or frequency associated with an overactive bladder.
Retrograde ejaculation (dry ejaculation), dry mouth, dizziness, constipation, blurred vision, and headache.
Swallow the tablet whole with a glass of water, preferably with a meal at the same time every day. Follow your physician's dosage instructions strictly and do not crush or chew the tablet.
Unsafe
Consult Your Doctor
Consult Your Doctor
Unsafe
Caution
Caution
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship.
While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
In case of any issue, contact us
E-mail address: support@zeptonow.com
Geddit Convenience Private Limited
Geddit Convenience Private Limited, Unit 508, Sakti Statesman, 5th floor, Green Glen Layout, No.37/301/34/1, SY.NO.34, Ibblur Village, Begur Hobli, Bangalore, Karnataka-560103
KA-B61-283317, KA-B61-283318
India
Alkem Laboratories Limited
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013
24 months
December 2026